CA2836313A1 - Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225 - Google Patents

Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225 Download PDF

Info

Publication number
CA2836313A1
CA2836313A1 CA2836313A CA2836313A CA2836313A1 CA 2836313 A1 CA2836313 A1 CA 2836313A1 CA 2836313 A CA2836313 A CA 2836313A CA 2836313 A CA2836313 A CA 2836313A CA 2836313 A1 CA2836313 A1 CA 2836313A1
Authority
CA
Canada
Prior art keywords
reaction mixture
chelation reaction
chelation
acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2836313A
Other languages
English (en)
Inventor
Alfred Morgenstern
Frank Bruchertseifer
Christos Apostolidis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
European Atomic Energy Community Euratom
Original Assignee
European Atomic Energy Community Euratom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Atomic Energy Community Euratom filed Critical European Atomic Energy Community Euratom
Priority to CA2836313A priority Critical patent/CA2836313A1/fr
Publication of CA2836313A1 publication Critical patent/CA2836313A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2836313A 2013-12-12 2013-12-12 Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225 Abandoned CA2836313A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2836313A CA2836313A1 (fr) 2013-12-12 2013-12-12 Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2836313A CA2836313A1 (fr) 2013-12-12 2013-12-12 Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225

Publications (1)

Publication Number Publication Date
CA2836313A1 true CA2836313A1 (fr) 2015-06-12

Family

ID=53365577

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2836313A Abandoned CA2836313A1 (fr) 2013-12-12 2013-12-12 Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225

Country Status (1)

Country Link
CA (1) CA2836313A1 (fr)

Similar Documents

Publication Publication Date Title
Di Bartolo et al. New 64 Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr
Zeglis et al. Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand diels–alder click chemistry
JP2831073B2 (ja) 大環状二官能キレート剤、その錯体及びそれらの抗体接合体
US6120768A (en) Dota-biotin derivatives
BR112020012099A2 (pt) radiomarcação de polipeptídeos
CA2768658C (fr) Procedes de generation de radioimmunoconjugues
Zhou et al. Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation
Paterson et al. Bifunctional 64 Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography
US20150157742A1 (en) SYNTHESIS OF BIOLOGICAL COMPOUNDS LABELED WITH THE ALPHA EMITTER Ac-225
EP2637705B1 (fr) Conjugués et leur utilisation en imagerie moléculaire
CA3222172A1 (fr) Procedes et materiaux permettant de combiner des produits biologiques avec de multiples chelateurs
Suzuki et al. Reduction of the Renal Radioactivity of 111In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes
CA2836313A1 (fr) Synthese de composes biologiques etiquetes avec l'emetteur alpha ac-225
CA2205360A1 (fr) Procedes d'utilisation de nouveaux lyoprotecteurs et formulations instantanees en kit pour produits radiopharmaceutiques utilisant lesdits lyoprotecteurs
AU698763B2 (en) Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
WO2023056474A1 (fr) Anticorps monoclonal anti-humain de souris dirigé contre la glypicane-3
EA045797B1 (ru) Радиоактивное мечение полипептидов
CA3229588A1 (fr) Procede de separation d'agregats
EP4396555A1 (fr) Procédé de séparation d'agrégats
CA3198721A1 (fr) Complexes radioactifs d'anticorps anti-her2 et produit radiopharmaceutique
Lewis Multimodality Imaging with Silica-Based Targeted Nanoparticle Platforms

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180910

FZDE Discontinued

Effective date: 20210311

FZDE Discontinued

Effective date: 20210311